1997-1999 Consultant neurology Department of neurology, Aust-Agder Hospital
1999-2000Consultant Department of neurosurgery, University hospital of Oslo
2000-2019 Consultant Department of neurology, Sørlandet Hospital
2019-2020 Neurologist Department of pediatrics habilitation, Sørlandet Hospital
2019-202 Neurologist Competence Center for children with prenatal alcohol/drug exposure
2020-2021 Infectious diseases control consultant Sørlandet Hospital
2021-2023 Associated professor at the University of Agder,Institut for health and nursing science
2014-DD Leader of The Norwegian National Advisory Unit on Tick-borne diseases, Sørlandet Hospital
2015-DD Research consultant Sørlandet Hospital
2023-DD Professor at the University of Agder, Institute for health and nursing science
Eikeland Randi (2012) European neuroborreliosis-long term follow up. University of Bergen, Faculty of Medisin. ISBN 978-82-308-2029-2
Ljøstad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A, Mygland A. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008 Aug;7(8):690-5. doi: 10.1016/S1474-4422(08)70119-4.
Quist-Paulsen E, Ormaasen V, Kran AB, Dunlop O, Ueland PM, Ueland T, Eikeland R, Aukrust P, Nordenmark TH. Encephalitis and aseptic meningitis: short-term and long-term outcome, quality of life and neuropsychological functioning. Sci Rep. 2019 Nov 6;9(1):16158. doi: 10.1038/s41598-019-52570-2.
Eikeland R, Ljøstad U, Helgeland G, Sand G, Flemmen HØ, Bø MH, Nordaa L, Owe JF, Mygland Å, Lorentzen ÅR. Patient-reported outcome after treatment for definite Lyme neuroborreliosis. Brain Behav. 2020 Apr;10(4):e01595. doi: 10.1002/brb3.1595.
Knudtzen FC, Eikeland R, Bremell D, Quist-Paulsen E, Johansen I, Solheim AM, Skarphedinsson. Lyme neuroborreliosis with encephalitis, a systematic literature review and a Scandinavian cohort study.Clin Microbiol Infect. 2021 PMID: 34768019.
Andreassen S, Lindland ES, Solheim AM, Beyer MK, Ljøstad U, Mygland Å, Lorentzen ÅR, Reiso H, Harbo HF, Løhaugen GCC, Eikeland R. Cognitive Function, fatigue and Fazekas score in patients with acute neuroborreliosis. Ticks Tick Borne Dis 2021 doi: 10.1016/j.ttbdis.2021.101678.
Andreassen S, Solheim AM, Ljøstad U, Mygland Å D, Lorentzen ÅR, Reiso H, Beyer MK, Harbo HF, Løhaugen GCC, Eikeland R. Cognitive function in patients with neuroborreliosis: A prospective cohort study from the acute phase to 12 months post treatment Brain and behaviour 2022 Doi: 10.1002/brb3.2608.
Halperin J, Eikeland R, Branda JA, Dersch R. Lyme neuroborreliosis, known knowns and known unknowns. Brain 2022 DOI: 10.1093/brain/awac206.
Solheim AM, Lorentzen ÅR, Dahlberg AO, Flemmen HØ, Brune S, Forselv KJN, Pripp AH, Bø MH, Eikeland R, Reiso H, Mygland Å, Ljøstad U.Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial J Neurol Neurosurg Psychiatry 2022 Jul 27;93(11):1222-1228. doi: 10.1136/jnnp-2022-329.
Sarjomaa M, Diep LM, Zhang C, Tveten Y, Reiso H, Thilesen C, Nordbø SA, Berg KK, Aaberge I, Pearce N, Kersten H, Vandenbroucke JP, Eikeland R, Fell AKM. SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway.2022 PLoS One. DOI: 10.1371/journal.pone.0264667.
Andreassen S, Lindland EMS, Beyer MK, Solheim AM, Ljøstad U, Mygland Å, Lorentzen ÅR, Reiso H, Bjuland KJ, Pripp AH, Harbo HF, Løhaugen GCC, Eikeland R. Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosisJ Neurol. 2023 Mar;270(3):1430-1438. doi: 10.1007/s00415-022-11463-7.
Akhvlediani T, Bernard-Valnet R, Diaz R, Eikeland R, Pfausler B, Sellner J. Neurological side effects and drug interactions of antiviral compounds against SARS-CoV-2 European Journal of Neurol. 2023 Aug EJoN-23-1206.R1
Last changed: 20.12.2023 13:12